文献速递泌尿生殖与妇科肿瘤放疗姑息放疗与转移瘤

局部晚期宫颈癌根治性放化疗患者长期患者报告困扰

Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation.
PubMed 文献 · Clin Transl Radiat Oncol · 2020-04-16

本研究评估局部晚期宫颈癌根治性放化疗(CRT)患者长期患者报告困扰。2011至2016年纳入完成至少2次修订版埃德蒙顿症状评估系统(ESAS-r)问卷的患者,采用线性混合模型分析纵向趋势。67例患者共736次评估,中位随访24个月,ESAS-r评分随时间显著下降,基线评分强烈预测随访评分,改善达最小临床重要差异(MCID)的患者比例随时间显著增加,恶化达MCID的比例显著减少,未发现困扰预测因素。

要点

  • 宫颈癌根治性放化疗后患者报告困扰随时间显著改善,改善程度达临床意义。
  • 基线ESAS-r评分强烈预测随访评分,提示早期识别高困扰患者的重要性。
  • 未发现困扰的预测因素,需将宫颈癌特异性患者报告结局工具纳入实践。

核心结论

  • 长期宫颈癌幸存者经历的困扰随时间显著改善,改善程度达患者预期的临床意义。
  • 将宫颈癌特异性患者报告结局工具纳入实践可更好了解患者需求。

研究设计与样本

  • 2011至2016年纳入接受根治性放化疗且完成至少2次ESAS-r问卷(含基线)的宫颈癌患者。
  • 采用线性混合模型评估ESAS-r纵向趋势,用移动平均描述达MCID患者比例,混合效应逻辑模型检验变化。
  • 共67例患者符合分析,包含736次ESAS-r评估。

主要发现

  • 中位随访24个月(范围15-45),12个月时问卷依从率60%(40/67)。
  • ESAS-r评分随时间显著下降。
  • 基线ESAS-r评分强烈预测随访ESAS-r评分(p < 0.001)。
  • 从基线改善达MCID的患者比例随时间显著增加(p < 0.001)。
  • 恶化达MCID的患者比例随时间显著减少(p < 0.001)。

关键数值与推荐

  • 总ESAS-r评分MCID定义为改善3分、恶化4分。

临床怎么用

  • 临床中可考虑将宫颈癌特异性患者报告结局工具纳入常规实践,以更好了解患者需求。
  • 关注基线ESAS-r评分较高的患者,因其随访困扰可能持续较高。

局限性

  • 12个月问卷依从率为60%(40/67),可能存在随访偏倚。
  • 未发现困扰预测因素,可能受样本量限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To evaluate longitudinal patient-reported distress in cervical cancer patients treated with definitive chemoradiation (CRT). MATERIALS AND METHODS: Between 2011 and 2016, consenting cervical cancer patients treated with definitive CRT who completed ≥ 2 revised Edmonton Symptom Assessment System (ESAS-r) questionnaires at clinical visits, including baseline, were included. A linear mixed model was used to assess the longitudinal trend in ESAS-r. A minimal clinically important difference (MCID) for total ESAS-r score was defined as a change of 3-points for improvement and 4-points for deterioration. The proportion of patients with an MCID over time was described using moving averages. To test for changes, mixed effects logistic models were fitted, each of which included patient-specific random intercepts and random slopes. RESULTS: 67 patients were eligible for analysis (736 ESAS-r assessments). Median (range) follow-up was 24 months (range: 15-45) and compliance at 12 months was 60% (40/67). There was a significant decrease in ESAS-r scores over time. Baseline ESAS-r was strongly predictive of ESAS-r at follow-up (p < 0.001). The proportion of patients with an MCID for improvement from baseline significantly increased over time (p < 0.001) and the proportion with an MCID for deterioration significantly decreased over time (p < 0.001). No predictors for distress were found. CONCLUSIONS: Long-term cervical cancer survivors experience distress that significantly improves over time to an extent expected to be clinically meaningful for patients. Implementing cervical cancer specific patient-reported outcome tools into practice could better inform patient needs.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Conway JL, Felder S, Tang J, et al. Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation. Clin Transl Radiat Oncol. 2020. PMID: 32368623. doi:10.1016/j.ctro.2020.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。